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Abbreviations
Cas  CRISPR-associated
Cascade  CRISPR-associated complex for antiviral 
defense
CRISPR  Clustered regularly interspaced short  
palindromic repeats
crRNA  CRISPR RNA
ds  Double-stranded
nt  Nucleotide
PAM  Protospacer-adjacent motif
RAMP  Repeat associated mysterious protein
RNP  Ribonucleoprotein
ss  Single-stranded
tracrRNA  Trans-activating CRISPR RNA
wT  wild-type
Introduction
Bacteriophages (or viruses of bacteria) are the most abun-
dant organisms in the biosphere. They infect bacteria in 
order to reproduce and usually kill the host cell when rep-
lication is completed. To evade this deadly threat, bacteria 
evolved multiple phage-resistance mechanisms (defence 
barriers) that interfere with nearly every step of phage life 
cycles [1, 2]. Bacteria, for example, mutate receptors to 
interfere with virus attachment to the cell surface, employ 
restriction enzymes to destroy viral DNA if it enters the 
cell, or even commit altruistic suicide to prevent produc-
tive virus propagation in the bacteria population. In gen-
eral, these anti-phage defence barriers often protect bacte-
ria from other invasive DNA molecules like plasmids and 
other integrative and conjugative elements [1, 2].
Phages overcome bacteria resistance by counter-evolv-
ing their genomes. Co-evolution of the T4 phage and 
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Escherichia coli restriction–modification system serves as 
a classical example of defence and counter-attack interac-
tions between phages and their bacterial hosts [3, 4]. The 
constant arms race ongoing between bacteria and viruses 
promotes the evolution and dissemination of bacterial bac-
teriophage-resistance mechanisms [5]. Not surprisingly, a 
large part of the bacteria genome is occupied by the genes 
encoding various antiviral defence systems [5]. Some 
defence barriers, like restriction–modification systems, are 
able to discriminate “self” versus “non-self” DNA, and in 
this respect function as a primitive innate immune system 
which confers resistance against invasive nucleic acids.
Recently, an adaptive microbial immune system, 
named clustered regularly interspaced short palindromic 
repeats (CRISPR) and which provides acquired immunity 
against viruses and plasmids, has been identified. It con-
sists of an array of highly conserved short DNA repeat 
(R) sequences (typically 21–48 bp long), which are inter-
spaced by stretches of variable sequence called spacers 
(S) (typically, between 26 and 72 bp) (Fig. 1). The spacer 
sequences generally originate from phage or plasmid DNA 
[6, 7]. A set of cas (CRISPR-associated) genes is typically 
located in the vicinity of the repeat-spacer array [8, 9]. The 
sequence and length of repeats are conserved within the 
specific CRISPR locus, but greatly diverge between dif-
ferent CRISPR systems [10, 11]. The number of repeat-
spacer units in one CRISPR loci varies from 2 to 249 [11, 
12]. Multiple CRISPR–Cas systems might be present in the 
same genome; the record holder is Methanocaldococcus 
jannaschii, which contains 18 CRISPR loci [11]. CRISPR–
Cas systems are widespread, and are found, as of May 7, 
2013, in 48 % of bacteria (in 1,025 species from 2,151 
sequenced) and more than 85 % of archaea (in 123 species 
from 145 sequenced) genomes [10].
The CRISPR–Cas mechanism is arbitrarily divided into 
three main steps: (1) adaptation or spacer acquisition, (2) 
expression and processing (crRNA generation), and (3) 
interference or silencing (Fig. 1). During adaptation, the 
Cas proteins recognize invasive DNA (bacteriophage or 
plasmid DNA) and integrate short pieces of the foreign 
DNA into the CRISPR region as new spacers [13–20]. 
From an immunological point of view, the adaptation step 
is analogous to the immunization of bacteria by an invasive 
nucleic acid and memorization of the invader. In this case, 
acquisition of a new trait by bacteria occurs by a horizontal 
transfer and follows a Lamarckian rather than a Darwin-
ian mechanism [21]. Next, the CRISPR repeat-spacer array 
is transcribed into a long primary RNA transcript that is 
further processed into a set of small CRISPR RNAs (crR-
NAs), containing a conserved repeat fragment and a varia-
ble spacer sequence (guide) complementary to the invading 
nucleic acid [22–24]. crRNAs further combine with Cas 
proteins into an effector complex, which recognizes the 
target sequence in the invasive nucleic acid by base pairing 
to the complementary strand of double-stranded DNA [25] 
or single-stranded RNA [24, 26], and induces sequence-
specific cleavage [14], thereby preventing proliferation 
and propagation of foreign genetic elements. Again, from 
an immunological point of view, the expression/interfer-
ence step would be analogous to the immune response of 
a “vaccinated” host against invasive nucleic acid. Thus, in 
contrast to other bacteriophage-resistance mechanisms, the 
CRISPR–Cas functions as invader-specific, adaptive and 
heritable microbial immune system that confers acquired 
resistance against viruses and plasmids.
CRISPR–Cas systems have been categorized into three 
main types, based on core elements content and sequences 
Fig. 1  The CRISPR–Cas adaptive microbial immune system con-
fers acquired resistance against invading nucleic acids. CRISPR array 
consists of short partially palindromic repeats (black diamonds) inter-
spaced by unique DNA sequences called spacers (colored squares). 
Cas genes (arrows) are encoded in the vicinity of the CRISPR array. 
The CRISPR–Cas mechanism is arbitrarily divided into three main 
stages: (1) adaptation or spacer acquisition, (2) expression and pro-
cessing (crRNA generation), and (3) interference or silencing. Dur-
ing adaptation, Cas proteins recognize invasive nucleic acid (NA) and 
integrate short pieces of foreign DNA into the CRISPR region as new 
spacers. Spacers are inserted at the leader (L) proximal end followed 
by duplication of the repeat. From the perspective of the microbial 
immune system, the adaptation step is analogous to the immuniza-
tion of bacteria by an invasive nucleic acid and memorization of the 
invader. In the expression and processing stage, the CRISPR repeat-
spacer array is transcribed into a long primary RNA transcript (pre-
crRNA) that is further processed into a set of small crRNAs, containing 
a conserved repeat fragment and a variable spacer sequence (guide) 
complementary to the invading nucleic acid. crRNAs further com-
bine with Cas proteins into an effector complex. In the interference or 
silencing stage, the effector complex recognizes the target sequence 
in the invasive nucleic acid by base pairing and induces sequence-
specific cleavage, thereby preventing proliferation and propagation 
of foreign genetic elements. From the perspective of the microbial 
immune system, the expression/interference step would be analo-




[27]. More than one CRISPR–Cas system type is usually 
found in one organism, suggesting that these systems are 
compatible and could share functional components [27, 
28]. Initially, four distinct genes encoding conserved Cas 
proteins were identified and named cas1–4 [8], but subse-
quent bioinformatic analyses have shown that Cas proteins 
are much more diverse. According to a current view, cas 
genes encode 65 sets of orthologous Cas proteins, which 
initially were classified into 45 different families but later 
cut to 25 families by applying more stringent classification 
criteria [9, 27, 29]. Only the cas1 and cas2 genes seem to 
be universal and found in the majority of CRISPR–Cas sys-
tems. each type is specified by the so-called signature pro-
tein, which is conserved in a particular type; accordingly, 
Cas3 in Type I, Cas9 in Type II, and Cas10 in Type III.
The mechanisms of the adaption/immunization step 
which include spacer selection and acquisition are still 
enigmatic. Cas1 and Cas2 proteins are involved in this 
process [15]; however molecular details remain obscure. 
The mechanisms underlying crRNA generation have been 
established for a number of CRISPR–Cas systems and are 
reviewed elsewhere [28, 30–38]. Here, we focus on the 
interference/immunity mechanisms employed by CRISPR–
Cas systems of different types.
DNA interference in Type I CRISPR–Cas systems
Type I systems are subdivided into six subtypes that dif-
fer by the number and arrangement of cas genes [27]. 
CRISPR–Cas locus of I-A subtype, as exemplified by Sul-
folobus solfataricus, is comprised of 12 cas genes, while 
subtype I-F in Pseudomonas aeruginosa contains only 6 
cas genes (Online Resource Fig. S1). Despite the differ-
ences, all Type I systems encode a hallmark Cas3 protein 
alongside a universally conserved Cas1 protein [27]. Type I 
CRISPR-mediated mechanisms of adaptive immunity have 
been explored for the six model organisms (Table 1). Two 
of them (E. coli and Streptococcus thermophilus) belong 
to the subtype I-e, while the other four are of I-A (S. sol-
fataricus), I-B (Haloferax volcanii), I-C (Bacillus halo-
durans), and I-F (P. aeruginosa) subtypes, respectively. 
Although the repeat length and sequences in the Type I 
CRISPR array vary between the model systems, nucleotide 
sequences within a repeat are partially palindromic, except 
for subtype I-A (Table 1). In the Type I systems, repeat-
spacer arrays are transcribed into a precursor crRNA (pre-
crRNA) where a palindromic sequence of the repeat forms 
a hairpin, which is recognized and processed by Cas6 or 
Cas5d endoribonucleases [22, 39] to generate a mature 
crRNA. crRNA is then incorporated into a large multisubu-
nit RNP complex, which together with Cas3 protein induce 
silencing of invasive DNA [28, 30–38].
Subtype I-e
Most of our knowledge on the mechanism of DNA inter-
ference in the I-e subtype comes from the studies of two 
model systems, namely E. coli K-12 CRISPR and Strepto-
coccus thermophilus DGCC7710 CRISPR4 (Table 1).
E. coli CRISPR–Cas system
Pioneering studies of the E. coli CRISPR system in the van 
der Oost laboratory provided a paradigm for DNA silenc-
ing in Type I systems [23]. The E. coli CRISPR–Cas sys-
tem encodes eight Cas proteins downstream of the CRISPR 
region (Online Resource Fig. S1) and five Cas proteins 
assemble into an effector complex that binds crRNA into 
a RNP complex called CRISPR-associated complex for 
antiviral defence (Cascade) [23]. ec-Cascade is a 405-
kDa complex comprised of five Cas proteins and crRNA  
with the following stoichiometry: (Cse1)1:(Cse2)2:(Cas7)6: 
(Cas5)1:(Cas6e)1:(crRNA)1 (Table 1) [23, 25, 40]. The 
mature 61-nt crRNA [25] identified in the ec-Cascade is 
comprised of a 32-nt spacer flanked by 8-nt 5′- and 21-nt 
3′-handles resulting from the pre-crRNA cleavage within 
repeat stems by the Cas6e endoribonuclease [41, 42]. ec-
Cascade using crRNA as a guide locates the target DNA in 
a process that has yet to be defined, and binds to the com-
plimentary DNA strand creating an R-loop, if a short proto-
spacer adjacent motif (PAM) [25] is present in the vicinity 
of matching protospacer. Initially, bioinformatic analysis 
identified the 5′-AwG-3′ PAM [43]  that was required for 
ec-Cascade binding and subsequent DNA interference 
[44]. On the other hand, experimental analysis of CRISPR 
repeat boundaries in E. coli suggests a dinucleotide 5′-Aw-
3′ as PAM, arguing that the last G nucleotide belongs to 
the protospacer sequence [45]. The molecular machinery 
of new spacer integration in E. coli recognizes the PAM 
sequence, of which 2 nt are outside a protospacer and the 
third G nucleotide becomes an integral part of a proto-
spacer [45]. The PAM definition in the E. coli system still 
remains controversial since the spacer integration analy-
sis in a non-laboratory E. coli strain identifies the AwG 
sequence as PAM [46].
Low resolution electron microscopy of the ec-Cascade 
reveals a sea-horse shape [25], which was later confirmed 
by sub-nanometer resolution structures [40]. In the ec-
Cascade, six copies of Cas7 assemble into a helical struc-
ture that provides a binding platform for crRNA and acts 
as a scaffold physically linking other Cas proteins. Both 
3′- and 5′-handles of crRNA originating from the con-
served repeat region are anchored by specific interac-
tions with Cas6e ribonuclease and 5′-proximal Cas7/Cse1 
subunits, respectively. On the other hand, the Cse2 dimer 
joining to the Cas7 oligomer creates an extended binding 

































































































































































































































































































































































































































































































































































































































































































































































































































































surface for the 3′-half of the crRNA spacer [40], and dis-
plays crRNA on the surface of a helical structure made by 
the Cas7 oligomer. Such binding mode protects crRNA 
from degradation but maintains base pairing potential with 
a complementary DNA target [28]. ec-Cascade binding to 
the target site culminating in R-loop formation is a com-
plicated process that involves a number of stages including 
recognition of an alien nucleic acid, PAM localization, and 
crRNA hybridization to the matching DNA strand. Molec-
ular details for different stages remain to be established; 
however, key players are already emerging. The Cse1 subu-
nit is presumably involved in PAM recognition by Cascade 
[47] and, at the same time, serves as a docking site for Cas3 
nuclease–helicase [48]. Furthermore, only seven nucleo-
tides proximal to the PAM in the target DNA seem  to be 
crucial for initiation of ec-Cascade binding, suggesting a 
similar role to the “seed” sequences in microRNA’s [49–
51]. The crRNA “seed” sequence in E. coli may play a role 
in the initial scanning of invader DNA for a perfect match 
before base pairing of the full-length spacer can occur [44]. 
The initial DNA strand opening may be triggered by dis-
tortion occurring upon ec-Cascade binding to the PAM 
sequence and is promoted by a negative supercoiling [48, 
52]. The role of DNA topology on ec-Cascade binding 
remains to be systematically investigated.
S. thermophilus CRISPR4–Cas system
The S. thermophilus DGCC7710 strain contains four dif-
ferent CRISPR systems which belong to three different 
Types [31] (Online Resource Fig. S2). Functional activity 
has been demonstrated in vivo for Type II-A CRISPR1 [13] 
and CRISPR3 [54] systems; however, neither spacer acqui-
sition nor interference activity has so far been reported for 
the CRISPR2 and CRISPR4 systems, which belong to the 
subtypes III-A and I-e, respectively. The St-CRISPR4–Cas 
of S. thermophilus DGCC7710 is orthologous to the I-e 
CRISPR–Cas system of E. coli discussed above [31, 53]. In 
the St-CRISPR4–Cas system, five cas genes are arranged 
into a cluster (cse1–cse2–cas7–cas5–cas6e) (Online 
Resource Fig. S2) analogous to the E. coli cas genes, sug-
gesting that corresponding Cas proteins may assemble into 
a homologous St-Cascade complex. Indeed, cloning and 
expression of the S. thermophilus CRISPR4 system in an 
E. coli strain lacking cas genes, enabled isolation and char-
acterization of the S. thermophilus Cascade (St-Cascade), 
which consists of five Cas proteins orthologous to the ec-
Cascade [55]. The stoichiometry of the St-Cascade was 
not directly determined; however, indirect data suggest 
that, similar to the ec-Cascade [25], the Cas7 protein is the 
most abundant protein in St-Cascade. Repeat sequences of 
E. coli and St-CRISPR4 systems differ by 8 nt, however 
the fragment corresponding to the GC rich hairpin stem 
in Ec-crRNA is conserved. Furthermore, the 61-nt length 
of crRNA co-purified with St-Cascade is consistent with 
a conserved cleavage position at the 21st nt of the repeat 
sequence [55] and implies a conserved mechanism of pre-
crRNA processing by Cas6e ribonuclease. In the S. thermo-
philus CRISPR4 system, the mature crRNAs is comprised 
of a 7-nt 5′-handle, a 33-nt spacer, and a 21-nt 3′-handle 
(Table 1). It is likely that the St-Cascade complex will be 
arranged into a similar sea-horse-like structure as estab-
lished for ec-Cascade [25, 40].
St-Cascade binding to the matching sequence in the 
target DNA requires a PAM sequence located in the vicin-
ity of a protospacer. In the St-CRISPR4 system, the PAM 
predicted by in silico analysis of the matching protospacer 
sequences in S. thermophilus phages is an AA dinucleotide 
located immediately upstream of the protospacer. Surpris-
ingly, the PAM identified in the in vitro binding assay is 
extremely promiscuous and limited to a single A(−1) 
or T(−1) nucleotide [55]. Of note is that in vitro binding 
affinities of the ec-Cascade and St-Cascade to the match-
ing DNA sequences containing optimal PAMs differ by 
at least two orders of magnitude [48, 55]. Taken together, 
these data demonstrate that (1) orthologous E. coli and 
St-CRISPR4 systems show different PAM dependencies, 
and (2) the requirements for the PAM stringency in St-
CRISPR4 may be different for the spacer acquisition and 
interference steps [16, 56].
Subtype I-F
The CRISPR–Cas system of P. aeruginosa encodes six cas 
genes (Online Resource Fig. S1). Biochemical and struc-
tural evidence indicate that four Cas proteins and crRNA 
assemble into a 350-kDa RNP complex (Pa-Cascade) of 
(Csy1)1:(Csy2)1:(Csy3)6:(Cas6f)1:(crRNA)1 stoichiometry. 
The complex contains 60 nt of mature crRNA comprised 
of a 32-nt spacer flanked by 8-nt 5′- and 20-nt 3′-handles 
which result from the pre-crRNA cleavage by the Cas6f 
endoribonuclease within a repeat stem [47, 57]. Like ec-
Cascade, Pa-Cascade binds to DNA targets containing 
crRNA matching sequences [58]. According to the phage 
challenge assay, the GG PAM is required for a new spacer 
acquisition by the CRISPR–Cas system of P. aeruginosa 
(Table 1). Isothermal titration calorimetry analysis shows 
that Pa-Cascade binding is enthalpically driven and gov-
erned by a “seed” sequence [58], similar to ec-Cascade [40, 
44]. Moreover, all nucleotides in PAM and seed sequences 
are important for protection from phage infection [59].
Structural analysis of the Pa-Cascade by native mass 
spectrometry, electron microscopy, and small-angle X-ray 
scattering reveals a crescent-shaped particle [58]. In gen-
eral, the overall shape and stoichiometry of the Csy effector 
complex are reminiscent of those for the ec-Cascade. The 
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Pa-Cascade, however, lacks the large extension  which is 
formed by Cse1 protein in ec-Cascade [58]. Since Cse1 is 
presumably involved in PAM recognition and target DNA 
selection [60], the mechanism of target localization and 
binding by ec-Cascade and Pa-Cascade may be different.
Subtype I-A
CRISPR–Cas systems of subtype I-A are more complex 
compared to I-e or I-F [27]. Three Type I-A CRISPR clus-
ters are identified in the S. solfataricus genome (Online 
Resource Fig. S1). In the largest Type I-A cluster com-
prised of 12 genes, the RNP complex pulled-down using 
a strep-tagged Cas7 (SSO1442) protein variant consists 
of crRNA and the Cas5 (SSO1441) protein. It was called 
aCascade (for archaeal Cascade) [61]; however, through-
out this review, we use the Ss-Cascade acronym to be 
consistent with acronyms for other complexes (Table 1). 
Minor amounts of Csa5 (SSO1443) and Cas6 (SSO1437) 
proteins co-purified with Ss-Cascade, suggesting weak 
interactions or transient complexes. In contrast to the I-e 
and I-F CRISPR–Cas systems, where the spacer length is 
fixed, the spacer in the I-A system varies from 38 to 44 
nt. Consequently, the crRNA co-purifying with Ss-Cas-
cade is between 60 and 70 nt, and contains an 8-nt 5′-tag 
(handle) and a 16–17-nt 3′-tag (handle) resulting from 
pre-crRNA cleavage by Cas6 in the unstructured repeat 
region [61]. According to electron microscopy data, Cas7 
proteins assemble into a helical structure [61] resembling 
ec-Cascade.
The crystal structure of Cas7 reveals a crescent-shaped 
three-domain architecture [61]. The ferredoxin-like 
domain, which is frequently employed for RNA binding, 
forms a Cas7 protein core. Two additional domains that are 
unique for the Type I-A Cas7 are inserted in the conserved 
ferredoxin-like domain [61]. Although the Cas7 structure 
provides no hints on the Cas7 oligomerization interface 
in the Ss-Cascade helical spine, it predicts putative amino 
acids residues that may interact with crRNA. Consistent 
with in silico prediction, the alanine replacement of the 
conserved His160 significantly decreases Cas7 protein 
affinity to the crRNA [61]. Moreover, Ss-Cascade reconsti-
tuted in vitro by mixing recombinant Cas7 and Cas5 pro-
teins with crRNA binds complementary single-stranded 
DNA; however, a double-stranded DNA target binding 
remains to be demonstrated [61].
Subtype I-B
Although the I-B effector complex has yet to be isolated 
and characterized in vitro, the in vivo experiments in 
H. volcanii provide a first glimpse into molecular details for 
I-B systems [62, 63]. H. volcanii encodes eight cas genes 
and three distinct CRISPR repeat-spacer arrays (Online 
Resource Fig. S1). The 30-nt repeat sequence in a pre-
crRNA forms a minimal hairpin stem comprised of three 
paired nucleotides and cleavage occurs within the stem 
base to yield an 8-nt 5′-tag (handle) and a 22-nt 3′-tag (han-
dle) in the mature crRNA. Interestingly, the crRNAs gen-
erated from the three distinct CRISPR repeat-spacer loci 
contain different 5′-terminal nucleotides (U, G, or A). Fur-
thermore, the spacer length in the H. volcanii I-B system 
varies between 34 and 39 nt, and therefore the length of the 
mature crRNA is between 64 and 69 nt [62]). The subtype 
I-B CRISPR–Cas system of H. volcanii provides interfer-
ence against invading plasmids if PAM sequences (TTC, 
ACT, TAA, TAT, TAG, and CAC) are located in the vicinity 
of the protospacer (Table 1) [62, 63].
Subtype I-C
The B. halodurans encodes seven cas genes arranged in 
the I-C cluster (Online Resource Fig. S1). Differently from 
other Type I systems, I-C does not encode the Cas6 protein 
required for crRNA maturation [27]. In the I-C CRISPR–
Cas system, the Cas5d protein replaces the Cas6 endori-
bonuclease and cleaves pre-crRNA to generate a mature 
crRNA [39, 64]. The repeat sequence in B. halodurans is 
partially palindromic and folds into a hairpin structure in 
the pre-crRNA. However, unlike the ec-Cas6 endoribo-
nuclease, the Cas5d cleaves at the base of hairpin to yield 
11-nt 5′- and 21-nt 3′-tags (handles) originating from the 
conserved repeat regions [39].
Cas5d recognizes both the hairpin structure of the repeat 
and a single-stranded RNA fragment at the 3′-end of the 
repeat. After pre-crRNA processing, one Cas5d subunit 
remains bound to the 3′-repeat handle, while another sub-
unit presumably interacts with the 8-nt 5′-repeat handle 
of matured crRNA. Finally, Cas5d together with crRNA, 
Cas8c (Csd1), and Cas7 (Csd2) proteins assemble into a 
400-kDa RNP complex following (Cas8c)1:(Cas7)6:(Cas5d)
2:(crRNA)1 stoichiometry (where Cas8c is an Cse1 ortholog 
in I-e) and exhibits spatial architecture similar to ec-Cas-
cade (Table 1) [39]. Interestingly, when Cas8c, Cas7, and 
Cas5d proteins are expressed in E. coli cells lacking one 
of ec-Cascade components (Cse1, Cas7, Cas5, or Cas6e, 
respectively) but containing endogenous E. coli CRISPR 
loci and Cas3, the silencing by the heterologous Type I-C 
system is restored, suggesting the possible complementation 
between different CRISPR-Cas systems [39, 65].
Cas3: a slicer for DNA in Type I systems
ec-Cascade binding to the matching sequence in the invad-
ing DNA does not trigger silencing; degradation of the for-
eign DNA requires an accessory Cas3 protein [23]. Cas3 is 
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a signature protein of the Type I systems [27] and typically 
contains HD phosphohydrolase and Superfamily 2 helicase 
domains arranged into a single subunit protein; however, 
sometimes, HD- and helicase-domains are encoded as indi-
vidual Cas3′ and Cas3″ subunits, respectively [9, 27, 29]. 
Furthermore, in some CRISPR systems, the single chain 
Cas3 or separate Cas3 domains are fused to other Cas pro-
teins (Cas2–Cas3, Cas3–Cse1) [27, 48]. Single chain Cas3 
variants from four different bacteria/archaea strains and 
Cas3 domains (subunits) have been purified and biochemi-
cally characterized (Table 2; Online Resource Figs. S1, S2).
Cas3 of S. thermophilus DGCC7710
Consistent with in silico predictions [9, 29], biochemical 
studies of St-Cas3 revealed that the N-terminal HD-domain 
is a single-stranded DNA nuclease, while the C-terminal 
helicase domain possesses a single-stranded DNA-stim-
ulated ATPase activity, which is coupled to unwinding of 
DNA/DNA and RNA/DNA duplexes in the 3′–5′ direc-
tion (Table 2) [53]. In vitro reconstitution of the Type I-e 
system of S. thermophilus DGCC7710 provided the first 
molecular details for the functional interplay between St-
Cascade and St-Cas3 [55]. St-Cas3 alone neither binds nor 
cleaves dsDNA and has no ATPase or helicase activity [53]. 
To unleash St-Cas3 full catalytic activity, a single-stranded 
DNA is required and St-Cascade contributes to its forma-
tion. St-Cascade binding to the dsDNA guided by crRNA 
creates an R-loop where the non-target strand of a proto-
spacer is expelled as ssDNA [55]. This displaced DNA 
strand in the St-Cascade–target DNA complex serves as a 
platform for the St-Cas3 binding and triggers ATPase and 
nuclease activities. The nuclease function of Cas3 located 
in the HD-domain seems to be coupled to ATP hydrolysis 
in the C-terminal helicase domain. Indeed, if ATP is miss-
ing, the single-stranded DNase activity of the HD domain 
is weak and cleavage is limited to the expelled non-target 
DNA strand. On the other hand, in the presence of ATP, the 
HD-nuclease of Cas3 produces multiple cuts beyond the 
protospacer region in the 3′–5′ direction, presumably due to 
the unwinding of DNA duplex by the C-terminal helicase. 
Interestingly, under these conditions, St-Cas3 also cleaves 
the crRNA-bound DNA strand either because of the strand 
switch or additional St-Cas3 molecule binding [55]. As a 
consequence, in the presence of ATP, the interplay between 
the nuclease and ATPase/helicase activities of St-Cas3 
results in the degradation of plasmid DNA. Of note is that, 
in the presence of ATP, a few nuclease cuts also occur in 
the DNA strand engaged in the heteroduplex with crRNA, 
suggesting a remodeling of the St-Cascade complex.
Cas3 of E. coli
Due to the poor solubility and a tendency to aggregate, the 
E. coli Cas3 protein (ec-Cas3) can only be expressed and iso-
lated in very limited amounts [48, 53, 66]. It has been shown 
recently that, in vivo, the ec-Cas3 protein interacts with the 
ec-Cascade complex via the Cse1 protein. Guided by this 
finding, westra et al. [48] have engineered an artificial ec-
Cas3–Cse1 protein fusion that was incorporated into the ec-
Cascade effector complex and provided resistance in vivo. 
Both HD-nuclease and helicase domains of ec-Cas3 were 
important for CRISPR-encoded immunity [48]. Moreover, the 
ec-Cas3–Cse1 fusion protein in the in vitro-reconstituted ec-
Cascade complex degraded plasmid DNA containing a crRNA 
matching protospacer sequence [48]. The ATPase/helicase 
Table 2  Biochemical properties of Cas3 proteins
a
 Two separate proteins
b
 Two separate proteins; only the HD domain carrying protein was purified and analyzed
c
 Only the HD domain was purified and analyzed
Organism Complex 
acronym
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St-Cas3 I-e HD-Helicase + 3′ → 5′ endo ssDNA – [53]
Thermus  
thermophilus HB8
Tt-Cas3 I-e HDc-Helicase nd nd endo ssDNA – [67]
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activity was required for the plasmid degradation suggesting 
that DNA unwinding may be important for the Cas3 func-
tion. The unwinding of DNA–RNA duplexes activity was also 
reported for the wT Cas3 from E. coli (Table 2) [66].
Cas3 from other Type I systems
The T. thermophilus HB8 Cas3 protein (Tt-Cas3) HD 
domain belonging to the subtype I-e CRISPR locus 
reveals Ni2+-dependent endonuclease activity on a single-
stranded DNA [67]. The cleavage pattern of the Tt-Cas3 
in the reconstituted effector complex including the Tt-
Cascade has yet to be established. The HD domain protein 
from the M. jannaschii (MjCas3′) (subtype I-A) displays 
Mg2+-dependent endo- and 3′ → 5′ exonuclease activity 
on single-stranded DNA and RNA, as well as on 3′-flaps, 
splayed arms, and R-loops, which represent the potential 
intermediates of DNA degradation [68]. The degradation of 
branched DNA substrates by MjCas3′ is stimulated by the 
helicase subunit (MjCas3″) and ATP. In contrast to all other 
biochemically characterized Cas3 proteins or HD domains 
(Table 2) that act on single-stranded nucleic acids, the HD-
type nuclease subunit (Cas3′) of S. solfataricus CRISPR–
Cas system has been reported to degrade double-stranded 
DNA and RNA with a preference to G or C bases [69].
Mechanism of DNA-interference in the Type I systems
In summary, biochemical and structural studies of the 
CRISPR-encoded immunity in the different Type I CRISPR–
Cas systems are consistent with a following general mech-
anism of DNA interference (Fig. 2): (1) crRNA is incor-
porated into a multisubunit RNP complex (Cascade); the 
Cascade complex composition and stoichiometry differ 
between different subtypes but the overall shape of the com-
plex shows a characteristic helical spine similar to the ec-
Cascade, (2) Cascade guided by the crRNA locates the tar-
get DNA site and, if the correct PAM sequence is present, 
binds to the matching DNA strand, creating an R-loop that 
serves as a loading site for the Cas3 protein, (3) Cas3 bind-
ing to the ssDNA triggers ATPase/helicase activity that pre-
sumably contributes to Cascade remodelling, making both 
DNA strands in the protospacer region available for Cas3 
cleavage, and (4) after cleaving both DNA strands within the 
protospacer, Cas3 translocates on the non-target strand in the 
3′ → 5′ direction in an ATP-dependent manner and cleaves 
the translocating strand using its HD-nuclease domain.
Accessory functions of Cascade and Cas3
The existing experimental evidence suggests that bind-
ing of the Cascade surveillance complex marks invasive 
DNA for destruction, while Cas3 actually acts as a slicer 
that degrades DNA to provide interference. Recent findings 
suggest that the CRISPR interference machinery (Cascade 
and Cas3) may also be important in the spacer acquisition 
(immunization) stage [16, 19]. Indeed, in the E. coli K12 
CRISPR system, the integration of new spacers from the 
infecting phage M13 DNA occurs more often, when crRNA 
is no longer capable of eliciting defence because the phage 
harbors an escape mutation in the protospacer (or PAM), 
but due to the low affinity binding ec-Cascade is still able 
to act as a priming site for a new spacer acquisition. The 
selection of new spacers is largely determined by the prim-
ing protospacer orientation and therefore the mechanism is 
termed priming [19, 70]. A similar mechanism may play a 
role in the acquisition of new spacers derived from the plas-
mid [16]. Indeed, when multiple spacers originating from 
the plasmid are integrated in the E. coli CRISPR loci, all 
spacers target the same strand of DNA, implying that the 
first acquired spacer directs strand selection for integration 
of successive spacers [16]. It has been proposed that Cas-
cade–crRNA binding to the matching protospacer sequence 
Fig. 2  DNA-interference in the Type I CRISPR–Cas systems. Cas-
cade scans DNA for a protospacer sequence and PAM. Once the 
correct PAM and a short primary hybridization sequence (“seed”) 
are identified (1), the crRNA basepairs with a complementary DNA 
strand forming R-loop (2). Displaced DNA strand of the R-loop 
serves as landing site for Cas3 (3). In the absence of ATP, the Cas3 
nuclease domain (HD) cleaves a displaced non-target strand within 
a protospacer (4) producing a nicked DNA (5). In the presence of 
ATP, Cas3 remodels the Cascade–DNA complex making both target 
and non-target strands available for the Cas3 cleavage within a proto-
spacer sequence (6). Cas3 further translocates in the 3′ → 5′ direc-
tion powered by a helicase domain (Hel) whereas the HD domain 
degrades DNA (6; 7) in a unidirectional manner (8)
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determines which strand will be extruded into the R-loop 
and subjected to degradation in the 3′ → 5′ direction [53, 
55]. In this way, the unidirectional DNA degradation by 
Cas3 may contribute to the selection of a specific DNA 
strand from which new spacers are subsequently acquired 
[19]. The molecular mechanism of Cas3 and Cascade in the 
primed spacer acquisition remains to be established.
In the Sulfolobus islandicus CRISPR system, Cas3 is 
presumably involved in the pre-crRNA maturation [71]. 
Indeed, in Δcas3′ and Δcas3″ mutants, pre-crRNA pro-
cessing intermediates accumulate, suggesting that the 
helicase and nuclease activities of Cas3 are important for 
the resolution of the processing intermediates and crRNA 
degradation in S. islandicus. Interestingly, Cas3 expression 
in E. coli also triggers cellular processes unrelated to the 
CRISPR-encoded immunity: in the presence of Cas3, the 
regulation of Cole1 replicon is impaired, resulting in the 
higher plasmid copy number [72]. The molecular details of 
Cas3 in the uncontrolled plasmid replication process have 
yet to be established, but the helicase domain of ec-Cas3 
seems to be involved. It is possible that the ec-Cas3 ability 
to process R-loops without DNA/RNA sequence-specificity 
and without Cascade may contribute to this process [66].
DNA interference in Type II CRISPR–Cas systems
In the Type II systems, cas genes operon encodes only three 
or four Cas proteins [27], including the universal Cas1 and 
Cas2 proteins, as well as Cas4 [73] or Csn2 [74–77], which 
are involved in the spacer acquisition stage [13, 78]. Type 
II systems are further subdivided into II-A, II-B, and II-C 
subtypes [27, 79]. Furthermore, all Type II CRISPR–Cas 
systems contain a conserved Cas9 signature protein [27]. 
Hence, the CRISPR-mediated mechanisms of immunity in 
the Type II systems must be different from those employed 
by Type I. First, the endoribonucleases (Cas6e or Cas5d) 
that are involved in the pre-crRNA processing in the Type 
I systems are missing in the Type II. Surprisingly, in the 
Streptococcus pyogenes II-A CRISPR–Cas system (Online 
Resource Fig. S1), a trans-encoded small RNA (called a 
trans-activating CRISPR RNA or tracrRNA) with 24-nt 
complementarity to the repeat regions of pre-crRNA, con-
tributes to the crRNA maturation in a process that requires 
host RNase III [80]. The importance of tracrRNA in the 
crRNA maturation pathway is now directly demonstrated 
for several Type II systems, and bioinformatic analysis pre-
dicts tracrRNA orthologs in most of the Type II systems 
[79–81]. Second, the Cas3 protein which is involved in the 
destruction of invading nucleic acids, is missing.
CRISPR-mediated mechanisms of an adaptive immunity 
for Type II systems have been explored for two model organ-
isms, namely, S. pyogenes and S. thermophilus DGCC7710 
(Table 3). S. thermophilus DGCC7710 carries two II-A sys-
tems (Online Resource Fig. S2), namely, St-CRISPR1 and 
St-CRISPR3, and both are active in vivo, e.g., are able to 
incorporate new spacers upon phage challenge and provide 
resistance in subsequent rounds of infection [13, 54]. Repeat 
sequences in the characterized II-A systems are 36 nt in 
length and partially palindromic (Table 3) [31]. Processing 
of the pre-crRNA in the presence of tracrRNA and RNase 
III results in the mature 42-nt crRNA which is considera-
bly shorter in comparison to the crRNA of Type I systems 
(Table 1). There are two major differences between mature 
crRNAs’ in II-A and Type I systems. First, crRNA in Type II 
lacks a 5′-handle and contains an extended 22-nt 3′-handle 
generated by the RNase III cleavage within the repeat region 
in the pre-crRNA:tracrRNA duplex. Second, the spacer 
fragment in the Type II crRNA is shorter, because the 5′-
end of the spacer sequence is trimmed to 20 nt by unknown 
nuclease(s). Consequently, the spacer in the mature crRNA 
matches only 20 of the 30-nt protospacer sequence in the 
invading nucleic acid. The non-matching fragment in the 
protospacer is not important for the CRISPR-mediated 
immunity; however, shortening of the protospacer sequence 
to 19 nt or more abrogates CRISPR-mediated plasmid inter-
ference [82–84]. Three model systems have been used to 
study mechanisms of invading nucleic acid destruction by 
Type II systems.
CRISPR3–Cas of S. thermophilus DGCC7710
The St-CRISPR3–Cas system (Online Resource Fig. S2) 
when transferred into E. coli confers protection against 
plasmid transformation and de novo phage infection [78]. 
The interference against phage and plasmid DNA provided 
by St-CRISPR3 requires the presence, within the target 
DNA, of a protospacer sequence complementary to the 
spacer-derived crRNA, and a conserved PAM sequence, 
NGGNG, located immediately downstream of the proto-
spacer (Table 3) [43, 54, 85, 86]. In the heterologous sys-
tem, cas9 is the sole cas gene necessary for the CRISPR-
encoded interference [78], suggesting that this protein is 
involved in crRNA processing and/or crRNA-mediated 
silencing of invasive DNA.
Cas9 of the S. thermophilus CRISPR3–Cas system is a 
large, multidomain protein comprising 1,409 amino acid 
residues [78]. It contains two nuclease domains, a RuvC-
like nuclease domain near the amino terminus and a HNH-
like nuclease domain in the middle of the protein. Muta-
tional analysis has established that interference provided 
in vivo by Cas9 requires both the RuvC and HNH motifs 
[78]. The Cas9 protein of the S. thermophilus CRISPR3–
Cas system co-purifies with a 42-nt crRNA and ~65-nt 
tracrRNA [81, 82]. Such a ternary complex cleaves both 
synthetic oligodeoxynucleotide and plasmid DNA bearing 
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a nucleotide sequence complementary to the crRNA, in a 
PAM-dependent manner. RuvC and HNH active sites of 
Cas9 are responsible for the cleavage of opposite DNA 
strands within a protospacer 3 nt away from the PAM 
sequence. Taken together, our data demonstrate that the 
Cas9–crRNA–tracrRNA (Cas9t) complex functions as an 
RNA-guided endonuclease that uses RNA for target site 
recognition and Cas9 for DNA cleavage.
CRISPR01–Cas of S. pyogenes
The S. pyogenes genome contains Sp-CRISPR01–Cas 
and Sp-CRISPR02–Cas loci that belong to Type II and 
Type I-C, respectively. The Sp-CRISPR01–Cas (Online 
Resource Fig. S1) is homologous to the St-CRISPR3–Cas 
[80]. Sp-Cas9 is responsible for the production of mature 
crRNAs and interference [80]. Jinek et al. isolated Sp-
Cas9 and demonstrated that it cleaves plasmid DNA or 
an oligonucleotide duplex if target contains a protospacer 
sequence complementary to the spacer-derived crRNA 
and a conserved PAM sequence, NGG, located immedi-
ately downstream of the protospacer (Table 3). The mature 
crRNA alone is incapable of directing Sp-Cas9 cleavage 
and requires accessory tracrRNA to trigger cleavage. Fur-
thermore, a dual-tracrRNA:crRNA engineered as a single 
RNA chimera supports Cas9-mediated dsDNA cleavage. 
Sp-Cas9 cleavage occurs in both DNA strands 3 nt away 
from the PAM sequence. The Cas9 HNH-nuclease domain 
cleaves the crRNA complementary strand, whereas the 
Cas9 RuvC-like domain cuts the non-complementary 
strand.
CRISPR1–Cas of S. thermophilus DGCC7710
The St-CRISPR1–Cas system is similar to that of the St-
CRISPR3–Cas in terms of the number and arrangement 
of associated cas genes (Online Resource Fig. S2). The 
repeat length is identical between the two systems and 
repeat sequences share 53 % of identity (Table 3). The 
St-CRISPR1–Cas system provides interference against 
invading nucleic acids by cleaving foreign DNA carrying 
a protospacer complementary to the spacer-derived crRNA, 
and a conserved PAM sequence, NNAAGAw, located 
immediately downstream of the protospacer [54, 85]. In 
vivo, the  CRISPR1–Cas system specifically cleaves plas-
mid and bacteriophage double-stranded DNA within the 
protospacer, 3 nt away from the PAM sequence [14]. The 
DNA cleavage position determined for the St-CRISPR1–
Cas system is identical to that of St-CRISPR3–Cas. Fur-
thermore, in the St-CRISPR1–Cas system, disruption of 
cas9 abolishes crRNA-mediated DNA interference in 
vivo [13, 14]. Therefore, it is likely that DNA cleavage 
occurs by the Cas9–crRNA complex; however, a detailed 
mechanism of DNA interference for St-CRISPR3–Cas has 
yet to be established.
Mechanism of DNA-interference in the Type II systems
In summary, genetic and biochemical studies of the 
CRISPR-encoded immunity in the Type II CRISPR–Cas 
systems are consistent with the following general mecha-
nism (Fig. 3) of DNA interference. First, the CRISPR 
repeat region is transcribed into a long primary pre-crRNA 
which pairs with tracrRNA and undergoes processing by 
host RNase III to generate a mature crRNA. Cas9 pro-
tein contributes to this stage by promoting the formation 
of the specific crRNA:tracrRNA duplex [81]. It is tempt-
ing to speculate that, in the Type II systems, Cas9-bound 
tracrRNA provides a scaffold for the crRNA binding and 
stabilization similarly to Cascade proteins in Type I and 
Cmr proteins in Type III systems [24–26, 40, 58, 61]. Sec-
ond, a ternary Cas9–crRNA–tracrRNA complex, using a 
mechanism that yet has to be defined, locates and binds to 
a protospacer sequence within the double-stranded DNA 
in a PAM-dependent process. The absolute requirement 
of PAM for dsDNA binding by the Cas9t complex implies 
that PAM serves as a priming site for strand separation or 
is essential for stabilization of the R-loop structure because 
dsDNA lacking PAM is not bound. The Cas9t binding to 
the target sequence in the dsDNA presumably results in 
an R-loop structure, where one DNA strand is displaced 
and the complementary strand is paired with the crRNA. 
PAM is located downstream of the protospacer and dif-
fers between different systems. For S. pyogenes it is NGG, 
and for S. thermophilus CRISPR1 and CRISPR3 systems, 
NAAGw and NGGNG, respectively. The PAM is required 
only for a double-stranded but not a single-stranded DNA 
binding and cleavage by Cas9t [82, 83]. Third, in the pres-
ence of Mg2+ ions, DNA is cleaved in both strands within 
a protospacer 3 nt upstream of the PAM sequence to gener-
ate blunt DNA ends. RuvC- and HNH-active sites of Cas9 
act on the opposite DNA strands. Taken together, the data 
demonstrate  that the Cas9–crRNA–tracrRNA complex 
functions as an RNA-guided endonuclease where sequence 
specificity is dictated by the crRNA while Cas9 provides 
the cleavage machinery. This establishes a molecular basis 
for CRISPR-mediated immunity in Type II systems, which 
solely rely on the signature Cas9 protein.
The simple modular organization of the Cas9t complex 
paves the way for the engineering of universal RNA-guided 
DNA endonucleases. while the proof of principle for re-
programmable RNA-guided endonucleases have been pro-
vided in the pioneering publications [82, 83], recent studies 
demonstrate that Cas9t can be employed for a precise edit-
ing of the human [87–90], mouse [89, 91], zebrafish [92, 
93], yeast [94], and bacteria [84] genomes. Furthermore, a 
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catalytically-deficient Cas9 variant was used in bacteria as a 
tool to specifically repress transcription through the crRNA 
binding [95]. Moreover, it has been reported [96] that in 
Francisella novicida, a Cas9 variant is involved in regulation 
of the bacterial gene contributing to the virulence by trigger-
ing proinflammatory innate immune response of the eukar-
yotic host. This finding may open the way for novel Cas9 
applications.
DNA interference in Type III CRISPR–Cas systems
Type III systems are more widespread in archaea that typi-
cally encode multiple CRISPR–Cas loci belonging to different 
subtypes [13–20]. Pyrococcus furiosus, for example, contains 
three Cas protein modules (subtypes I-A, I-B, and III-B) and 
seven CRISPR arrays [24, 97]. The archaeon S. solfataricus 
holds five Cas protein modules (two belonging to subtype 
III-B and three—subtype I-A) and six CRISPR arrays, respec-
tively [26]. The Type III CRISPR immune system, however, 
is not a hallmark of archaeal species. Lactic acid bacterium 
S. thermophilus DGCC7710 accommodates four different 
CRISPR–Cas loci in the chromosome including the III-B 
(Online Resource Fig. S2) [31]. Other bacteria, including 
important pathogens such as mycobacteria and staphylococci, 
also harbor Type III systems [98].
The Type III CRISPR–Cas systems encode a signature 
Cas10 protein that bears palm-domain polymerase-specific 
sequence motifs. Multiple RAMP-family proteins, which 
are built around a ferredoxin-like fold and are often 
involved in RNA-binding, are present in the Type III sys-
tems [9, 27, 99–101]. Type III systems are further classi-
fied into III-A and III-B subtypes. Most of our knowledge 
on the III-A subtype comes from the Staphylococcus epi-
dermidis model system, while S. solfataricus and P. furio-
sus, have been used as model systems for III-B (Online 
Resource Fig. S1). Intriguingly, two different Type III 
systems seem to target different nucleic acids. In Type 
III-B systems of S. solfataricus and P. furiosus, the Cas 
RAMP module (Cmr) and the crRNA complex recognize 
and cleave synthetic RNA in vitro [24, 26], whereas the 
Type III-A system of S. epidermidis targets DNA in vivo 
(Table 4) [98]. On the other hand, the III-B system from 
S. islandicus interferes with plasmid DNA transformation 
via transcription-dependent DNA targeting and relies on 
the direct protospacer transcription into RNA [102].
Unlike repeat sequences in Type I systems, the III-B 
subtype repeats are non-palindromic [12]. Nevertheless, 
pre-crRNA processing in the Type III systems is performed 
by the Cas6 endoribonuclease that contains a conserved 
ferredoxin-like fold, but, unlike the Cas6 of the Type I 
system, uses a different protein surface to interact with a 
non-palindromic repeat sequence. Processing of crRNA 
in P. furiosus occurs in two steps. Firstly, Cas6 of P. furio-
sus cuts pre-crRNA within a repeat region to yield a 66- 
to 72-nt 1× intermediate [22, 103, 104]. Secondly, subse-
quent degradation of the 3′-end of the 1× intermediate by 
unknown nucleases yields two crRNA populations, 45 and 
39 nt in length, that both contain a conserved 8-nt 5′-handle 
originating from the repeat region but trimmed at 3′-end. 
Accordingly, mature crRNA contains 37 and 31 nt belong-
ing to the spacer region [24].
The repeat sequence in the III-A subtype, as exempli-
fied by S. epidermidis, is partially palindromic [105]. Pre-
crRNA processing in vivo requires Cas6, Csm4, and/or 
Cas10 proteins and cleavage occurs at the base of the hair-
pin stem [105]. The cleavage pattern of pre-crRNA presum-
ably follows a mechanism similar to that of Cas6 endori-
bonuclease of Type I-e and I-F systems [41, 42, 57], and 
Se-Cas6 most likely is involved in pre-crRNA processing in 
S. epidermidis. Further maturation of the 1× intermediate 
proceeds via 3′-end trimming to yield 43- and 37-nt crRNAs 
and requires Csm2, Csm3, and Csm5 proteins [105].
The mechanism of invading nucleic acid degradation has 
been studied in vitro for the Type III-B systems of P. furiosus 
and S. solfataricus, and in vivo for the III-A system of S. epi-
dermidis. effector complexes of P. furiosus and S. solfataricus 
(Pf-Cmr and Ss-Cmr complexes) have been purified and 
biochemically characterized. Unlike other CRISPR–Cas  
systems that target DNA, both III-B effector complexes target 
single-stranded RNA (Table 4) [24, 26, 106].
Fig. 3  DNA-interference in the Type II CRISPR–Cas systems. The 
Cas9–crRNA–tracrRNA ternary complex  scans DNA for a proto-
spacer sequence and PAM. Once the correct PAM and a short pri-
mary hybridization sequence (“seed”) are identified (1), the crRNA 
basepairs with a complementary DNA strand forming R-loop (2). 
Once the R-loop is formed, Cas9 cuts both target and non-target 
DNA strands using the RuvC and the HNH active sites, respectively 
(3). Cleavage occurs 3 nt before PAM, yielding blunt-end DNA 
products (4)

































































































































































































































































































































































































































































































































































































































































































































































































































































































effector complex of P. furiosus (Pf-Cmr) consists of six 
Cas proteins (Cas10, Cmr1, and Cmr3–6) and crRNA that 
originates from seven distinct spacer-repeat arrays. The Pf-
Cmr complex cleaves complementary target RNA in vitro 
at the fixed 14 nt distance from the 3′-end of the crRNAs 
(Table 4). Because mature crRNAs of P. furiosus are of two 
different lengths, 39 and 45 nt, respectively, the target RNA 
is cleaved at two distinct positions, implying that the Pf-
Cmr complex uses a molecular ruler mechanism [24]. The 
active Pf-Cmr complex can be assembled in vitro by mixing 
six individual recombinant Cas proteins with 39- or 45-nt 
crRNA. The 8-nt 5′-handle of crRNA is critical for Pf-Cmr 
complex activity, and synthetic crRNAs bearing 5′-handle 
can be used to direct cleavage of novel targets [106]. On 
the other hand, biochemical analysis reveals that Cmr5 is 
dispensable for RNA cleavage activity, therefore the can-
didate protein responsible for RNA cleavage remains to be 
established [24]. evidence that supports in vivo functional-
ity of this system has recently been reported [106].
The hallmark Cas10 protein of Type III systems is a 
multidomain protein that has a permutated HD superfam-
ily nuclease domain at the N-terminus, followed by a zinc 
finger and polymerase-like domains [27]. HD-domain is 
important for DNA degradation by the Cas3 protein in the 
Type I systems; however, it seems to be dispensable for Pf-
Cmr-mediated RNA cleavage in vitro [107]. Crystal struc-
ture of the truncated Cas10 version from P. furiosus lacking 
the HD domain (Cas10 ΔHD) shows structural similarities 
to an adenylyl-cyclase rather than a polymerase. Moreo-
ver, mutations of the conserved ATP and divalent metal ion 
binding residues have no effect on RNA cleavage activity 
of the Pf-Cmr complex [107]. It has been shown recently 
that Cas10 interacts with the Cmr3 protein that shares simi-
larity to Cas6e and Cas6f proteins [109, 110]. Thus, it is 
likely that Cas10 plays a structural rather than a catalytic 
role in the Pf-Cmr complex [107, 108].
S. sulfolobus
The Cmr complex purified from S. sulfolobus (Ss-Cmr) 
consists of seven Cas proteins (Cmr1, Cas10, and Cmr3–7) 
and crRNA of various length (Table 4). Interestingly, the 
Cmr7 protein is present only in S. solfataricus species. In 
contrast to the Pf-Cmr complex that exploits a molecular 
ruler mechanism for the target RNA cleavage, the Ss-Cmr 
complex cleaves RNA at UA dinucleotides in a sequence-
specific manner. Moreover, the Ss-Cmr complex cleaves 
both target and guide RNA (crRNA) sequences in vitro, 
although a single crRNA molecule supports the degrada-
tion of multiple RNA targets [26]. The electron micros-
copy structure of the Ss-Cmr complex and the sub-complex 
including only Cas10, Cmr3, and Cmr7 proteins shows a 
clamp-like structure containing a deep cleft, which could 
accommodate double-stranded RNA [26].
S. epidermidis
S. epidermidis RP62A strain harbors a single III-A CRISPR 
locus containing nine cas genes flanked by three repeat-
spacer units. The targeting mechanism in the S. epidermidis 
model system is not fully understood and is limited to in 
vivo studies. Furthermore, the effector complex composi-
tion remains to be established. Nevertheless, in vivo stud-
ies reveal two important clues: (1) in contrast to the III-B 
systems, the protospacer DNA, rather than corresponding 
mRNA is targeted by the III-A CRISPR–Cas systems, and 
(2) III-A systems are PAM-independent and prevention of 
autoimmunity is achieved by checking the complementarity 
between the crRNA 5′-handle and the 3′-flanking sequence 
in the vicinity of the protospacer. The perfect match that 
will occur in the repeat region specifies self DNA while a 
mismatch tags alien DNA and triggers destruction [111]. 
However, it remains to be demonstrated that DNA target is 
cleaved in vitro by the Type III-A effector complex.
Mechanism of DNA-interference in the Type III systems
In summary, genetic and biochemical studies of the 
CRISPR-encoded immunity in the Type III CRISPR–Cas 
systems are consistent with the following general mecha-
nism of interference (Fig. 4). Firstly, the CRISPR repeat 
region is transcribed into a long primary pre-crRNA which 
undergoes a two-step processing to yield mature crRNA of 
two different lengths which contain an 8-nt 5′-handle origi-
nating from the repeat sequence and trimmed spacer 3′-
end. Despite the differences in repeat sequences (partially 
Fig. 4  Interference in the Type III CRISPR–Cas systems. In the case 
of the Type III-B CRISPR–Cas system, the Cmr complex scans RNA 
and crRNA basepairs with a matching protospacer sequence (1). Two 
different RNA cleavage mechanisms are proposed. The Cmr complex 
from P. furiosus exploits the ruler mechanism to introduce cuts in the 
target RNA 14 nt from the 3′-end of crRNA (2) to yield two product 
fragments (3). The Cmr complex of S. sulfolobus guided by crRNA 
cuts the target RNA in a sequence-specific manner at UA dinucleo-
tides (4) at multiple positions (5). The Cmr complex components 
involved in the cleavage have yet to be established
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palindromic vs. non-palindromic in the III-A and III-B sys-
tems, respectively), Cas6 ribonuclease contributes to the 
primary processing stage. Secondly, the mature crRNA in 
the Type III-B system is incorporated into an effector com-
plex which targets RNA in vitro using crRNA as a guide. 
The complex composition, stoichiometry, and mechanisms 
of the target RNA degradation in vitro differ  between 
P. furiosus and S. solfataricus complexes. The nucleases 
involved in the target RNA (Type III-B) or DNA (Type 
III-A) cleavage remain to be established. Thirdly, unlike 
the effector complexes of Type I and Type II systems, the 
effector complexes of III-A and III-B systems achieve 
interference in a PAM-independent manner.
Concluding remarks
CRISPR–Cas systems provide acquired immunity against 
viruses and plasmids and come in different flavors. Despite 
the differences, the silencing of the invading nucleic acid 
(DNA for Type I and II, RNA for Type III-B) includes an 
obligatory cleavage step, and in all cases crRNA is used 
as a guide to address the cleavage machinery to the target 
site. The effector complex that binds crRNA and triggers 
cleavage differs strikingly between different CRISPR sub-
types. In most of the Type I systems studied to date, crR-
NAs are incorporated into a multisubunit effector complex 
called Cascade (CRISPR-associated complex for antiviral 
defence), which binds to the target DNA and triggers deg-
radation by a signature Cas3 protein. The composition of 
the Cascade differs between subtypes, but in all cases it is 
arranged as a multisubunit aggregate that provides a scaf-
fold for crRNA binding. In the Type II systems, the effec-
tor complex functions as an RNA-guided endonuclease 
where sequence specificity is dictated by the crRNA while 
Cas9 provides the cleavage machinery. It is likely that, in 
the Type II systems, tracrRNA provides a scaffold for the 
crRNA binding. In Type III-B CRISPR–Cas systems of S. 
solfataricus and P. furiosus, the Cas RAMP module (Cmr) 
and crRNA effector complexes recognize and cleave syn-
thetic RNA in vitro. In the Type I systems, the Cas3 heli-
case/nuclease acts as a slicer that degrades invading foreign 
DNA. In the Type II systems, Cas9 protein cuts both DNA 
strands within a protospacer using two different active sites 
that act on opposite DNA strands. Despite recent progress 
in deciphering mechanisms of CRISPR-mediated immu-
nity, it remains to be established: (1) how interference is 
achieved in the Type III-A CRISPR–Cas systems, (2) how 
the effector complex locates the target site in the invading 
nucleic acid, (3) how supercoiling contributes to the tar-
get site location/cleavage in the CRISPR systems acting 
on DNA, and (4) how PAM is recognized. The answers 
to these and other questions will contribute to further 
understanding of the molecular mechanisms of CRISPR-
encoded immunity, and will open new avenues for future 
applications of CRISPR systems in biotechnology.
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